Letter to the Editor: Induction therapy as a long-term commitment: Lessons from comparative outcomes of alemtuzumab and basiliximab. [PDF]
Galassi L +4 more
europepmc +1 more source
From Challenge to Opportunity: ABO-Incompatible Kidney Transplantation to Expand the Donor Pool at a Single Center. [PDF]
Khullar D +15 more
europepmc +1 more source
Outcomes of basiliximab <i>vs</i> alemtuzumab induction in kidney allograft recipients with matched immunological Profiles: A retrospective cohort study. [PDF]
Chukwu CA +5 more
europepmc +1 more source
Rethinking chronic kidney disease risk after liver transplantation. [PDF]
Sessa C, Gembillo G, Morale W.
europepmc +1 more source
Short-Term Silymarin Supplementation After Kidney Transplantation Is Associated with Reduced Early Albuminuria: A Prospective Cohort Study. [PDF]
Vnučák M +6 more
europepmc +1 more source
Toward equitable transplant protocols: Thymoglobulin vs. Basiliximab in African-American kidney transplantation shows higher infection risk without survival benefit. [PDF]
Tobar L +7 more
europepmc +1 more source
Biologics in Kidney Transplantation: Why and How Should We Personalize Their Dosage? [PDF]
Arrivé C +3 more
europepmc +1 more source
Abatacept as maintenance therapy in kidney transplantation: a retrospective comparative study. [PDF]
Uro-Coste C +11 more
europepmc +1 more source
Subcutaneous Alemtuzumab as Salvage Therapy for Acute Kidney Transplant Rejection Following Thymoglobulin Anaphylaxis: A Pediatric Case Report. [PDF]
O'Connor KW +4 more
europepmc +1 more source
Simultaneous Liver-Kidney Transplantation from a Deceased Donor for Glycogen Storage Disease Type Ia: A Case Report. [PDF]
Hirata Y +10 more
europepmc +1 more source

